Stockysis — AI-Powered Stock News & Sentiment Analysis

TriSalus Life Sciences Affirms FY2026 Sales Guidance of $60.000M-$62.000M

Benzinga Newsdesk www.benzinga.com Negative 46.0%

Neg 46% Neu 0% Pos 0%

TriSalus Life Sciences (NASDAQ:TLSI) affirms FY2026 sales outlook from $60.000 million-$62.000 million to $60.000 million-$62.000 million.

Comments

No comments yet. Be the first!